{
  "attach_pages": "3",
  "attach_size": "580",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP201704270535187153_1.pdf?1513423678000.pdf",
  "company_code": "10000296",
  "eitime": "2017-04-27 11:22:05",
  "extend": {},
  "info_code": "AP201704270535187153",
  "language": "0",
  "notice_date": "2017-04-27 00:00:00",
  "notice_title": "血制品盈利能力提升，重组迎来市值重估",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "publish_relation": {
    "originalCode": "465",
    "publishName": "化学制药"
  },
  "rating": "A",
  "researcher": "朱国广,陈铁林",
  "security": [
    {
      "market_uni": "1",
      "publish_relation": [
        {
          "originalCode": "1044",
          "publishName": "生物制品"
        }
      ],
      "short_name": "天坛生物",
      "short_name_ch": "天坛生物",
      "short_name_cht": "天壇生物",
      "short_name_en": "BTBP",
      "stock": "600161"
    }
  ],
  "short_name": "天坛生物",
  "source_sample_name": "西南证券",
  "star": "3"
}